Statesville, N.C.-based Iredell Health System is participating in two research studies to develop blood tests that can detect cancer before symptoms occur. They are made possible through the partnership with Oracle Cerner and Elligo Health Research, which help facilitate the technology to dozens of health systems that might not be able to do it on their own.
“Iredell Health System strives to be your local community hospital, and our values and mission pointed us in the direction of inspiring wellness, which means we need to be a leader in healthcare delivery and prevention of illness,” said Joseph Mazzola, DO, the system’s vice president of medical affairs, in a March 6 news release. “The goal is to identify cancer at the earliest stage so that treatment will be most effective.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
